Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
KNSA holding history
Kiniksa Pharmaceuticals International, plc in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KNSA overviewAll 13F holders of KNSAFull Q2 2026 holdings
- Shares (Q2 2026)
- 304,080
- Value
- $19.4M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 304,080 | $19.4M | <0.1% | −382,773−55.7% | Reduced | Holders |
| Q1 2026 | 686,853 | $33.1M | <0.1% | −79,438−10.4% | Reduced | Holders |
| Q4 2025 | 766,291 | $31.6M | <0.1% | +76,403+11.1% | Added | Holders |
| Q3 2025 | 689,888 | $26.8M | <0.1% | −198,476−22.3% | Reduced | Holders |
| Q2 2025 | 888,364 | $24.6M | <0.1% | +653,236+277.8% | Added | Holders |
| Q1 2025 | 235,128 | $5.22M | <0.1% | −185,002−44.0% | Reduced | Holders |
| Q4 2024 | 420,130 | $8.31M | <0.1% | +31,774+8.2% | Added | Holders |
| Q3 2024 | 388,356 | $9.71M | <0.1% | +388,356 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −128,821−100.0% | Sold out | Holders |
| Q1 2024 | 128,821 | $2.54M | <0.1% | +34,322+36.3% | Added | Holders |
| Q4 2023 | 94,499 | $1.66M | <0.1% | +17,562+22.8% | Added | Holders |
| Q3 2023 | 76,937 | $1.34M | <0.1% | −42,951−35.8% | Reduced | Holders |
| Q2 2023 | 119,888 | $1.69M | <0.1% | −6,802−5.4% | Reduced | Holders |
| Q1 2023 | 126,690 | $1.36M | <0.1% | +126,690 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −32,141−100.0% | Sold out | Holders |
| Q3 2021 | 32,141 | $366.0K | <0.1% | +32,141 | New | Holders |